TXNRD1 and cancer: Alternatively, TR1 is overexpressed in many cancer cells [9]–[12] and its inhibition by a variety of potent cancer drugs altered cancer-related properties of numerous tumors and malignant cells suggesting that this enzyme is a target for cancer therapy [9]–[12], [14], [15].